Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Ovarian Neoplasms × Bleomycin × Clear all

Sponsor

Conditions

Hodgkin Disease 11 Lymphoma 9 Testicular Neoplasms 1 Teratoma 1 Sertoli-Leydig Cell Tumor 1 Recurrence 1 Ovarian gynandroblastoma 1 Ovarian Germ Cell Cancer 1 Lymphoma, Follicular 1 Granulosa cell tumor of the ovary 1 Gliosarcoma 1 Glioblastoma 1 Endodermal Sinus Tumor 1 Central Nervous System Neoplasms 1 Breast Neoplasms 1 Ann Arbor Stage IIB Hodgkin Lymphoma 1

Interventions

Paclitaxel 80 Carboplatin 76 Bevacizumab 53 Gemcitabine 29 pembrolizumab 27 liposomal doxorubicin 27 Topotecan 22 olaparib 19 Taxes 17 niraparib 15 Docetaxel 15 Immunoglobulin G 14 Disulfides 14 Cyclophosphamide 14 Cisplatin 11 durvalumab 10 Nivolumab 9 Doxorubicin 8 Albumin-Bound Paclitaxel 8 sargramostim 7 rucaparib 7 fludarabine phosphate 7 fludarabine 7 pazopanib 6 epacadostat 6 avelumab 6 Trabectedin 6 Magnetic Resonance Spectroscopy 6 Ipilimumab 6 Interleukin-2 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡